KAZANO (Takeda Pharmaceuticals America, Inc.)
Welcome to the PulseAid listing for the KAZANO drug offered from Takeda Pharmaceuticals America, Inc.. This Biguanide [EPC],Biguanides [Chemical/Ingredient],Dipeptidyl Peptidase 4 Inhibitors [MoA],Dipeptidyl Peptidase 4 Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Takeda Pharmaceuticals America, Inc. |
| NON-PROPRIETARY NAME: | alogliptin and metformin hydrochloride |
| SUBSTANCE NAME: | ALOGLIPTIN BENZOATE; METFORMIN HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Biguanide [EPC],Biguanides [Chemical/Ingredient],Dipeptidyl Peptidase 4 Inhibitors [MoA],Dipeptidyl Peptidase 4 Inhibitor [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2013-01-25 |
| END MARKETING DATE: | 0000-00-00 |
KAZANO HUMAN PRESCRIPTION DRUG Details:
| Item Description | KAZANO from Takeda Pharmaceuticals America, Inc. |
| LABELER NAME: | Takeda Pharmaceuticals America, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 12.5; 500(mg/1; mg/1) |
| START MARKETING DATE: | 2013-01-25 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 64764-335_21fe473e-7ecf-483e-9003-a95200b5433b |
| PRODUCT NDC: | 64764-335 |
| APPLICATION NUMBER: | NDA203414 |
Other ALOGLIPTIN BENZOATE; METFORMIN HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
